Gustavo Viani: Can PLND Be Avoided in Prostate Cancer?
Gustavo Viani, Professor of Radiation Oncology at Ribeirão Preto Medical School, shared a post on X, about a paper by Reha-Baris Incesu et al. published in Nature.
“Can PLND Be Avoided in Prostate Cancer?
A study shows that negative PSMA PET can help intermediate-risk prostate cancer skip pelvic lymph node dissection (PLND) during radical prostatectomy.
Outcomes:
- BCR-free survival: 78.7% (PLND) vs. 76.7% (no PLND) (p = 0.8)
- 90% accuracy in ruling out lymph node invasion (LNI).
Skipping PLND may complications without compromising outcomes.
Safer surgery, same results!”
Authors: Reha-Baris Incesu, Felix Preisser, Florian Nohe, Tobias Maurer, Markus Graefen, Derya Tilki.
More posts featuring Gustavo Viani.
Gustavo Viani, MD is an Associate Professor in the Department of Medical Imaging, Hematology, and Oncology at Hospital das Clínicas, Faculty of Medicine of Ribeirão Preto, University of São Paulo (FMRP-USP). Dr. Viani’s research focuses on radiation oncology, with expertise in brachytherapy, stereotactic radiosurgery, dose fractionation, radiation tolerance, and overall oncology practices.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023